Report Overview
The Nocturia market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nocturia market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nocturia companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Astellas Pharma
Allergan
Ferring Pharmaceuticals
Eli Lilly
GlaxoSmithKline
Sanofi
Pfizer
Abbott
Teva
Mylan
Johnson & Johnson
Hainan Zhonghe Pharmaceutical
Product Type Insights
Global markets are presented by Nocturia type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Nocturia are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Nocturia segment by Type
Desmopressin
Anticholinergic Drugs
Alpha Blockers
Diuretics
Others
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Nocturia market and what implications these may have on the industrys future. This report can help to understand the relevant market and consumer trends that are driving the Nocturia market.
Nocturia Segment by Sale Channels
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Nocturia market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nocturia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Nocturia and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Nocturia industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nocturia.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Nocturia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Table of Contents
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Nocturia by Type
- 2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
- 1.2.2 Desmopressin
- 1.2.3 Anticholinergic Drugs
- 1.2.4 Alpha Blockers
- 1.2.5 Diuretics
- 1.2.6 Others
- 2.3 Nocturia by Sale Channels
- 2.3.1 Market Value Comparison by Sale Channels (2018 VS 2022 VS 2029)
- 2.3.2 Hospital Pharmacies
- 2.3.3 Retail Pharmacies
- 2.3.4 Online Pharmacies
- 2.4 Assumptions and Limitations
- 3 Nocturia Breakdown Data by Type
- 3.1 Global Nocturia Historic Market Size by Type (2018-2023)
- 3.2 Global Nocturia Forecasted Market Size by Type (2023-2028)
- 4 Nocturia Breakdown Data by Sale Channels
- 4.1 Global Nocturia Historic Market Size by Sale Channels (2018-2023)
- 4.2 Global Nocturia Forecasted Market Size by Sale Channels (2018-2023)
- 5 Global Growth Trends
- 5.1 Global Nocturia Market Perspective (2018-2029)
- 5.2 Global Nocturia Growth Trends by Region
- 5.2.1 Global Nocturia Market Size by Region: 2018 VS 2022 VS 2029
- 5.2.2 Nocturia Historic Market Size by Region (2018-2023)
- 5.2.3 Nocturia Forecasted Market Size by Region (2024-2029)
- 5.3 Nocturia Market Dynamics
- 5.3.1 Nocturia Industry Trends
- 5.3.2 Nocturia Market Drivers
- 5.3.3 Nocturia Market Challenges
- 5.3.4 Nocturia Market Restraints
- 6 Market Competitive Landscape by Players
- 6.1 Global Top Nocturia Players by Revenue
- 6.1.1 Global Top Nocturia Players by Revenue (2018-2023)
- 6.1.2 Global Nocturia Revenue Market Share by Players (2018-2023)
- 6.2 Global Nocturia Industry Players Ranking, 2021 VS 2022 VS 2023
- 6.3 Global Key Players of Nocturia Head office and Area Served
- 6.4 Global Nocturia Players, Product Type & Application
- 6.5 Global Nocturia Players, Date of Enter into This Industry
- 6.6 Global Nocturia Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
- 6.1 Global Top Nocturia Players by Revenue
- 7 North America
- 7.1 North America Nocturia Market Size (2018-2029)
- 7.2 North America Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
- 7.3 North America Nocturia Market Size by Country (2018-2023)
- 7.4 North America Nocturia Market Size by Country (2024-2029)
- 7.5 United States
- 7.6 Canada
- 8 Europe
- 8.1 Europe Nocturia Market Size (2018-2029)
- 8.2 Europe Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
- 8.3 Europe Nocturia Market Size by Country (2018-2023)
- 8.4 Europe Nocturia Market Size by Country (2024-2029)
- 7.4 Germany
- 7.5 France
- 7.6 U.K.
- 7.7 Italy
- 7.8 Russia
- 7.9 Nordic Countries
- 9 Asia-Pacific
- 9.1 Asia-Pacific Nocturia Market Size (2018-2029)
- 9.2 Asia-Pacific Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
- 9.3 Asia-Pacific Nocturia Market Size by Country (2018-2023)
- 9.4 Asia-Pacific Nocturia Market Size by Country (2024-2029)
- 8.4 China
- 8.5 Japan
- 8.6 South Korea
- 8.7 Southeast Asia
- 8.8 India
- 8.9 Australia
- 10 Latin America
- 10.1 Latin America Nocturia Market Size (2018-2029)
- 10.2 Latin America Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
- 10.3 Latin America Nocturia Market Size by Country (2018-2023)
- 10.4 Latin America Nocturia Market Size by Country (2024-2029)
- 9.4 Mexico
- 9.5 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Nocturia Market Size (2018-2029)
- 11.2 Middle East & Africa Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
- 11.3 Middle East & Africa Nocturia Market Size by Country (2018-2023)
- 11.4 Middle East & Africa Nocturia Market Size by Country (2024-2029)
- 10.4 Turkey
- 10.5 Saudi Arabia
- 10.6 UAE
- 12 Players Profiled
- 11.1 Astellas Pharma
- 11.1.1 Astellas Pharma Company Detail
- 11.1.2 Astellas Pharma Business Overview
- 11.1.3 Astellas Pharma Nocturia Introduction
- 11.1.4 Astellas Pharma Revenue in Nocturia Business (2017-2022)
- 11.1.5 Astellas Pharma Recent Development
- 11.2 Allergan
- 11.2.1 Allergan Company Detail
- 11.2.2 Allergan Business Overview
- 11.2.3 Allergan Nocturia Introduction
- 11.2.4 Allergan Revenue in Nocturia Business (2017-2022)
- 11.2.5 Allergan Recent Development
- 11.3 Ferring Pharmaceuticals
- 11.3.1 Ferring Pharmaceuticals Company Detail
- 11.3.2 Ferring Pharmaceuticals Business Overview
- 11.3.3 Ferring Pharmaceuticals Nocturia Introduction
- 11.3.4 Ferring Pharmaceuticals Revenue in Nocturia Business (2017-2022)
- 11.3.5 Ferring Pharmaceuticals Recent Development
- 11.4 Eli Lilly
- 11.4.1 Eli Lilly Company Detail
- 11.4.2 Eli Lilly Business Overview
- 11.4.3 Eli Lilly Nocturia Introduction
- 11.4.4 Eli Lilly Revenue in Nocturia Business (2017-2022)
- 11.4.5 Eli Lilly Recent Development
- 11.5 GlaxoSmithKline
- 11.5.1 GlaxoSmithKline Company Detail
- 11.5.2 GlaxoSmithKline Business Overview
- 11.5.3 GlaxoSmithKline Nocturia Introduction
- 11.5.4 GlaxoSmithKline Revenue in Nocturia Business (2017-2022)
- 11.5.5 GlaxoSmithKline Recent Development
- 11.6 Sanofi
- 11.6.1 Sanofi Company Detail
- 11.6.2 Sanofi Business Overview
- 11.6.3 Sanofi Nocturia Introduction
- 11.6.4 Sanofi Revenue in Nocturia Business (2017-2022)
- 11.6.5 Sanofi Recent Development
- 11.7 Pfizer
- 11.7.1 Pfizer Company Detail
- 11.7.2 Pfizer Business Overview
- 11.7.3 Pfizer Nocturia Introduction
- 11.7.4 Pfizer Revenue in Nocturia Business (2017-2022)
- 11.7.5 Pfizer Recent Development
- 11.8 Abbott
- 11.8.1 Abbott Company Detail
- 11.8.2 Abbott Business Overview
- 11.8.3 Abbott Nocturia Introduction
- 11.8.4 Abbott Revenue in Nocturia Business (2017-2022)
- 11.8.5 Abbott Recent Development
- 11.9 Teva
- 11.9.1 Teva Company Detail
- 11.9.2 Teva Business Overview
- 11.9.3 Teva Nocturia Introduction
- 11.9.4 Teva Revenue in Nocturia Business (2017-2022)
- 11.9.5 Teva Recent Development
- 11.10 Mylan
- 11.10.1 Mylan Company Detail
- 11.10.2 Mylan Business Overview
- 11.10.3 Mylan Nocturia Introduction
- 11.10.4 Mylan Revenue in Nocturia Business (2017-2022)
- 11.10.5 Mylan Recent Development
- 11.11 Johnson & Johnson
- 11.11.1 Johnson & Johnson Company Detail
- 11.11.2 Johnson & Johnson Business Overview
- 11.11.3 Johnson & Johnson Nocturia Introduction
- 11.11.4 Johnson & Johnson Revenue in Nocturia Business (2017-2022)
- 11.11.5 Johnson & Johnson Recent Development
- 11.12 Hainan Zhonghe Pharmaceutical
- 11.12.1 Hainan Zhonghe Pharmaceutical Company Detail
- 11.12.2 Hainan Zhonghe Pharmaceutical Business Overview
- 11.12.3 Hainan Zhonghe Pharmaceutical Nocturia Introduction
- 11.12.4 Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2017-2022)
- 11.12.5 Hainan Zhonghe Pharmaceutical Recent Development
- 11.1 Astellas Pharma
- 13 Report Conclusion
- 14 Disclaimer